Cancer

RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai’s Platform to Develop a New AI Control System for Clinical AI Performance and Safety

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation…

1 month ago

Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise statedVANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics…

1 month ago

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class…

1 month ago

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™…

1 month ago

Defence’s Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC)

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

1 month ago

RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024

STOCKHOLM, Nov. 29, 2024 /PRNewswire/ -- RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December…

1 month ago

Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan

SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that…

1 month ago

Mainz Biomed Announces Stock Split

BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

1 month ago

RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution

SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables…

1 month ago

The McGill University Health Centre’s Dr. Renzo Cecere wins the 2024 Trottier Webster Innovation Award

The McGill University Health Centre’s Dr. Renzo Cecere wins the 2024 Trottier Webster Innovation Award Marie-Hélène Laramée, Dr Renzo Cecere,…

1 month ago